Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sanofi Restructures R&D Group | Contract Pharma

What are you searching for?

Sign in
Breaking News

Sanofi Restructures R&D Group

To eliminate 466 jobs in France and Germany as part of a reorganization to focus on its immuno-oncology pipeline and gene therapies

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi is restructuring its R&D group and plans to eliminate 466 jobs in France and Germany as part of a reorganization to focus on its immuno-oncology pipeline and gene therapies.
 
The company plans to exit cardiology research and focus on its existing assets and in-licensed clinical-phase drugs in this area. Also, the company’s diabetes research will focus on drugs that address the underlying causes of the disease but Sanofi will continue to develop its existing diabetes pipeline.
 
Sanofi plans to expand gene therapy R&D in the U.S., where it has a focused group in Massachusetts, and will further invest in antibody engineering in Germany. The changes may also include reorganizing R&D activities among its sites in France in an effort to use its resources more efficiently.
 
“The transformation of our R&D organization would enable us to focus on the therapeutic areas and platforms where we believe we have the greatest opportunity to make a meaningful difference for patients and to maximize the productivity of our research engine,” said John Reed head of R&D at Sanofi.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics